We welcome contributions to this Bibliography. We are especially interested in items which focus on the Canadian context. If there are any items that are missing which you think should be there, please email references to healthandbusiness@cbern.ca .

Agrawal, S., et al. (2004). "A prospective before-and-after trial of an educational intervention about pharmaceutical marketing." Academy Med 79(11): 1046-1050.  

Ashker, S., et al. (2007). "Pharmacy residents' attitudes toward pharmaceutical industry promotion." AM J Health Syst Pharm 64(16): 1724-1731.

Ashmore, R., et al. (2007). "Mental Health Nursing Students' Relationships with the Pharmaceutical Industry." Nurse Education Today 27(6): 551-560.  

Boyce, K., et al. (2003). "Industry sponsorship of continuing medical education." JAMA 290(9): 1149.  

Brenna, T., et al. (2006). "Health Industry Practices That Create Conflict of Interest: A Policy Proposal for Academic Medical Centers." JAMA 295(4): 429-433.  

Brodkey, A. (2005). "The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem." Academic Psychiatry 29(2): 222-229.  

Brodkey, A. C. (2005). "The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem." Academic Psychiatry 29: 222-229.  

Carroll, A. E., et al. (2007). "To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-Trainee and Industry-Physician Relationships?" Pediatrics 120(6): e1528-e1535.  

Chakrabarti, A., et al. (2002). "Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies." Ann R coll Physicians Surg Can 35(8): 541-546.  

Coleman, D., et al. (2006). "Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach." Acad Med 81(2): 154-160.

(top)

Davis, D. (2004). "CME and the pharmaceutical industry: two worlds, three views, four steps." CMAJ 171(2): 149-150.  

Elliot, C. (2004). "Pharma Goes to the Laundry: Public Relations and the Business of Medical Education." The Hastings Center Report 34: 18-23.

Geppert, C. (2007). "Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training." Academic Psychiatry 31(1): 32-39.

Heaphy, D., et al. (2004). "Industry Funding for Continuing Medical Education: Is it Ethical?" Arch Opthalmol 122(5): 771-773.  

Hensley, S. (2002). When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure. Wall Street Journal. New York. East Ed.  

Katz, H. P., et al. (2002). "Academia-Industry Collaboration in Continuing Medical Education: Description of Two Approaches." Journal of Continuing Education in the Health Professions 22(1): 43-54.  

Keim, S., et al. (2004). "Interactions between emergency medicine programs and the pharmaceutical industry." Acad Emerg Med 11(1): 19-26.  

Koch, D. (2003). "Industry Support for Physician Education." Cataract Refract Surg. 29(3): 419.

Lexchin, J., Cassels, A. (2005). "Does the C in CME stand for "Continuing" or "Commercial"?" CMAJ 172(2): 160-162.

Marlow, B. (2004). "The future sponsorship of CME in Canada: industry, government, physicians or a blend?" CMAJ 171(2): 150-151.  

Monaghan, M., et al. (2003). "Student understanding of the relationship between the health professions and the pharmaceutical industry." Teaching and Learning in Medicine 15(1): 14-20.

Morgan, J., et al. (2005). "Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies." Heart 91(6): 710-712.  

Moynihan, R. (2003). "Drug company sponsorship of education could be replaced at a fraction of its cost." BMJ 326(7400): 1163.  

Mueller, P. S., et al. (2007). "Physician Preferences and Attitudes Regarding Industry Support of CME Programs." The American Journal of Medicine 120(3): 281-285.

(top)

Packer, S., Parke, DW. (2004). "Ethical Concerns in Industry Support of Continuing Medical Education: The Con Side." Arch Opthalmol 122(5): 773-776.  

Relman, A. S. (2003). "Defending professional independence: ACCME's proposednew guidelines for commercial support of CME." JAMA 289(18): 2418-2420.  

Rentmester, C. (2005). "Pharma PR or Medical Education?" Hastings Cent Rep. 35 (2): 6.

Richter, L. (2005). "Corporate sponsorships in dental education: solution or sellout?" CDS Review 98(5): 12-17.  

Schneider, J., et al. (2006). "Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention." Academic Medical 81(7): 595-602.

Sierles, F., et al. (2005). "Medical Students' Exposure to and Attitudes About Drug Company Interactions: A National Survey." JAMA 294(9): 1034-1042.  

Spalding, P., . Bradley, RE. (2006). "Commercialization of dental education: have we gone too far?" J AM Coll Dent 73(3): 30-35.  

Steinbrook, R. (2005). "Commercial support and continuing medical education." The New England Journal of Medicine 352(6): 534-535.  

Steinman, M., Baron, RB. (2007). "Is continuing medical education a drug-promotion tool?: YES." Can Fam Physician 53(10): 1650-1657.  

Sterward, D. (2003). "A proposal to enhance the disclosure of potential conflict of interest for continuing medical education events." Teach Learn Med. 15(4): 267-269.  

Sudzina, M. (2005). "Industry Support for Dental Education." AM Coll Dent 72(2):12-14.  

Susman, J. (2004). "Commercial sponsorship of CME: there are alternatives." J Fam Pract 53(9): 679,690.

(top)

Van Harrison, R. (2003). "The uncertain future of continuing medical education: commercialism and shifts in funding.." Journal of Continuing Education in the Health Professions 23(4): 198 209.

Varley, C., et al. (2005). "A survey of the interactions between psychiatry residency programs and the pharmaceutical industry." Academic Psychiatry 29(1): 40-46.  

Watkins, R., Kimberly, J. (2004). "What residents don't know about physician pharmaceutical industry interactions." Academic Medical 79(5): 432-437.

Watson, P., et al. (2005). "Resident and faculty perceptions of conflict of interest in medical education." Journal of General Internal Medicine 20(4): 357-359.  

Wazana, A., et al. (2004). "Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry." Academic Medical 79(11): 1033-1040.

Wilson, F. (2003). "Continuing Medical Education: Ethical Collaboration Between Sponsor and Industry." Clin Orthop Relat Res. 412: 33-37.  

Wofford, J. L., et al. (2005). "Teaching appropriate interactions with pharmaceutical company representatives: The impact of an innovative workshop on student attitudes." OHL. BMC Med Educ. 5  

Wurth, G. (2003). "Orthopaedic research and education foundation and industry." Clin Orthop Relat Res. 412: 54-56.  

Zipkin, D., Steinman, MA. (2005). "Interactions between pharmaceutical representatives and doctors in training. A thematic review." Journal of General Internal Medicine 20(8): 777-786.

(top)